Cheng Fu-Xiang, Chen Tian
Zhongguo Zhen Jiu. 2014 Jul;34(7):627-30.
To verify the clinical efficacy on post-stroke dysphagia treated with acupuncture at Lianquan (CV 23).
One hundred and eighty patients were randomized into an acupuncture A group, an acupuncture B group and a rehabilitation group, 60 cases in each one. On the basis of the conventional medication, in the acupuncture A group, acupuncture was applied at Lianquan (CV 23); in the acupuncture B group, acupuncture was applied at Hegu (LI 4) and Neiguan (PC 6) and in the rehabilitation group, the swallowing rehabilitation training was adopted. The treatment was given once a day, 5 times a week, and the 4 weeks of treatment was required in all of the groups. The national institute of health stroke scale (NIHSS) and TV X-ray fluoroscope swallowing scale (VFSS) were used to evaluate neurologic deficit and swallowing function before and after treatment in the patients of each group. The morbidity of pneumonia and clinical efficacy were compared among the groups.
The scores of NIHSS and VFSS were improved apparently after treatment in the patients of the three groups (all P < 0.05) and the results in the acupuncture A group were superior to those in the other two groups (all P < 0.05). The morbidity of pneumonia in the acupuncture A group was lower than that in the acupuncture B group and the rehabilitation group [3.3% (2/60) vs 6.7% (4/60), 8.3% (5/60), both P < 0.05]. The effective rate in the acupuncture A group was better than that in either of the other two groups [95.0% (57/60) vs 81.7% (49/ 60), 75.0% (45/60), both P < 0.05].
On the basis of the conventional medication, acupuncture at Lianquan (CV 23) effectively improves the swallowing function, relieves neurological deficit and reduces the morbidity of pneumonia in the patients of post-stroke dysphagia.
验证针刺廉泉穴(CV 23)治疗中风后吞咽困难的临床疗效。
将180例患者随机分为针刺A组、针刺B组和康复组,每组60例。在常规药物治疗的基础上,针刺A组针刺廉泉穴(CV 23);针刺B组针刺合谷穴(LI 4)和内关穴(PC 6);康复组采用吞咽康复训练。治疗每日1次,每周5次,所有组均需治疗4周。采用美国国立卫生研究院卒中量表(NIHSS)和电视X线透视吞咽量表(VFSS)评估各组患者治疗前后的神经功能缺损和吞咽功能。比较各组肺炎发病率及临床疗效。
三组患者治疗后NIHSS和VFSS评分均明显改善(均P < 0.05),且针刺A组结果优于其他两组(均P < 0.05)。针刺A组肺炎发病率低于针刺B组和康复组[3.3%(2/60)比6.7%(4/60),8.3%(5/60),均P < 0.05]。针刺A组有效率优于其他两组[95.0%(57/60)比81.7%(49/60),75.0%(45/60),均P < 0.05]。
在常规药物治疗基础上,针刺廉泉穴(CV 23)能有效改善中风后吞咽困难患者的吞咽功能,缓解神经功能缺损,降低肺炎发病率。